FEATURED COMPANIES
- Abbott Laboratories
- AM-Pharma
- B. Braun Melsungen AG
- F. Hoffmann-La Roche
- LG Chem Ltd.
- Randox Laboratories
The Global Acute Kidney Injury Treatment Market is estimated to be USD 1.6 Bn in 2021 and is expected to reach USD 2.52 Bn by 2026, growing at a CAGR of 9.5%.
Market Dynamics
The increasing prevalence of acute kidney injury is a major factor inclining the global acute kidney injury treatment market. According to the National Kidney Foundation, around 37 million people in the US are affected by kidney diseases. The increasing geriatric population, unhealthy diet, high consumption of alcohol has increased the risk of kidney injury. In addition, Acetaminophen and other drugs overdose, hepatitis and autoimmune diseases, metabolic diseases are also factors burgeoning market growth. Furthermore, increasing healthcare expenditure and government initiatives in improving the healthcare system is anticipated to increase the market revenue. However, the high cost of dialysis treatment and lack of patient compliance for a long-term treatment plan is hampering the market growth.
Major players are investing in developing novel treatments, which is expected to offer remunerative growth opportunities for the player operating in the market.
Market Segmentation
The Global Acute Kidney Injury Treatment Market is segmented further based on Type, Treatment, End User, and Geography.
By Type, the market is classified into prerenal, intrinsic renal, and postrenal. Amongst all, the prerenal segment is estimated to hold the highest market share during the forecast period.
By Treatment, the market is classified as dialysis and drug therapy. Amongst the two, the dialysis segment is estimated to hold the highest market share during the forecast period.
By End User, the market is classified as hospitals, diagnostic centers, specialty clinics, ambulatory surgical centers, and others. Amongst all, the hospitals segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
Recent Developments
1. Angion and Vifor pharma announce the completion of enrollment in phase 2 study of ANG-3777 for cardiac-surgery associated acute kidney injury. - 29th April 2021.
2. AM-pharma announces enrollment of the first patient in revival phase 3 pivotal trial in patients with sepsis-associated acute kidney injury. - 12th November 2020.
Company Profiles
Some of the companies covered in this report Quark Pharmaceuticals, Inc, Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, LG Chem Ltd., Asahi Kasei Medical Co., Ltd, B. Braun Melsungen AG, Alloksys Life Sciences BV, etc.
Competitive Quadrant
The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
Report Highlights:
Market Dynamics
The increasing prevalence of acute kidney injury is a major factor inclining the global acute kidney injury treatment market. According to the National Kidney Foundation, around 37 million people in the US are affected by kidney diseases. The increasing geriatric population, unhealthy diet, high consumption of alcohol has increased the risk of kidney injury. In addition, Acetaminophen and other drugs overdose, hepatitis and autoimmune diseases, metabolic diseases are also factors burgeoning market growth. Furthermore, increasing healthcare expenditure and government initiatives in improving the healthcare system is anticipated to increase the market revenue. However, the high cost of dialysis treatment and lack of patient compliance for a long-term treatment plan is hampering the market growth.
Major players are investing in developing novel treatments, which is expected to offer remunerative growth opportunities for the player operating in the market.
Market Segmentation
The Global Acute Kidney Injury Treatment Market is segmented further based on Type, Treatment, End User, and Geography.
By Type, the market is classified into prerenal, intrinsic renal, and postrenal. Amongst all, the prerenal segment is estimated to hold the highest market share during the forecast period.
By Treatment, the market is classified as dialysis and drug therapy. Amongst the two, the dialysis segment is estimated to hold the highest market share during the forecast period.
By End User, the market is classified as hospitals, diagnostic centers, specialty clinics, ambulatory surgical centers, and others. Amongst all, the hospitals segment is estimated to hold the highest market share during the forecast period.
By Geography, North America is projected to lead the market.
Recent Developments
1. Angion and Vifor pharma announce the completion of enrollment in phase 2 study of ANG-3777 for cardiac-surgery associated acute kidney injury. - 29th April 2021.
2. AM-pharma announces enrollment of the first patient in revival phase 3 pivotal trial in patients with sepsis-associated acute kidney injury. - 12th November 2020.
Company Profiles
Some of the companies covered in this report Quark Pharmaceuticals, Inc, Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, LG Chem Ltd., Asahi Kasei Medical Co., Ltd, B. Braun Melsungen AG, Alloksys Life Sciences BV, etc.
Competitive Quadrant
The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
- The report offers a comprehensive evaluation of the Global Acute Kidney Injury Treatment Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
- The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report also contains a competitive analysis using the Positioning Quadrants, the analyst’s Proprietary competitive positioning tool.
Report Highlights:
- A complete analysis of the market, including parent industry
- Important market dynamics and trends
- Market segmentation
- Historical, current, and projected size of the market based on value and volume
- Market shares and strategies of key players
- Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Acute Kidney Injury Treatment Market
What is the estimated value of the Global Acute Kidney Injury Treatment Market?
What is the growth rate of the Global Acute Kidney Injury Treatment Market?
What is the forecasted size of the Global Acute Kidney Injury Treatment Market?
Who are the key companies in the Global Acute Kidney Injury Treatment Market?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- AM-Pharma
- B. Braun Melsungen AG
- F. Hoffmann-La Roche
- LG Chem Ltd.
- Randox Laboratories
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Influencers
5 Market Analysis
6 Global Acute Kidney Injury Treatment Market, By Type
7 Global Acute Kidney Injury Treatment Market, By Treatment
8 Global Acute Kidney Injury Treatment Market, By End User
9 Global Acute Kidney Injury Treatment Market, By Geography
10 Competitive Landscape
11 Company Profiles
12 Appendix
Note: Product cover images may vary from those shown
- Abbott Laboratories
- Acon Laboratories
- Alloksys Life Sciences B.V
- AM-Pharma
- Angion Biomedica Corp
- Asahi Kasei Medical Co., Ltd
- B. Braun Melsungen AG
- Baxter International, Inc.
- Beckman Coulter, Inc.
- F. Hoffmann-La Roche
- Fresenius Medical Care AG & Co. KGaA
- Ischemix, Inc.
- LG Chem Ltd.
- Quark Pharmaceuticals, Inc
- Quest Diagnostics
- Randox Laboratories
- Siemens Healthineers
- Silver Creek Pharmaceuticals, Inc.
- Stealth Bio Therapeutics, Inc.
- Sysmex Corporation
Note: Product cover images may vary from those shown